Published 11 August 2009, doi:10.1136/bmj.b3273
Cite this as: BMJ 2009;339:b3273

News

Heart risk scoring system used by NICE may overestimate lipid disorders

¹ London

The first 150 words of the full text of this article appear below.

The scoring system recommended in national guidelines for assessing patients’ cardiovascular risk may overestimate the number of people in England who need treatment for lipid disorders and may be missing others, a new analysis indicates.

Lipid modification guidelines from the National Institute for Health and Clinical Excellence (NICE), which were published in May 2008, advise doctors to use a modified version of the Framingham algorithm to check patients’ 10 year cardiovascular risk and decide whether they need drug treatment to reduce raised cholesterol concentrations.

But a new analysis by epidemiologists at the University of Oxford and commissioned by the Department of Health says that the choice of risk scoring system was based on "incorrect and severely misleading" findings (www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_103341). The analysis, some of the results of which were published in the BMJ in July (BMJ 2009;339:b2584, doi:10.1136/bmj.b2584), adds that these findings, from researchers at the . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study

Gary S Collins and Douglas G Altman
BMJ 2009 339: b2584. [Abstract] [Full Text] [PDF]

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

Julia Hippisley-Cox, Carol Coupland, Yana Vinogradova, John Robson, Margaret May, and Peter Brindle
BMJ 2007 335: 136. [Abstract] [Full Text] [PDF]

Online poll

Find out more here>> and here>>